Donanemab in Early Symptomatic Alzheimer Disease
“The TRAILBLAZER-ALZ 2 Randomized Clinical Trial”
Journal of the American Medical Association (JAMA), July 17, 2023
“The TRAILBLAZER-ALZ 2 Randomized Clinical Trial”
Journal of the American Medical Association (JAMA), July 17, 2023
Annals of Internal Medicine, June 27, 2023
New England Journal of Medicine July 27, 2023